Of noteworthy, the results demonstrated that CBX7 high mRNA expression was significantly correlated to longer RFS in patients who treated with tamoxifen only (HR=0.74, p=0.037) (Figure 6I), indicating a potential role of CBX7 in contribution to tamoxifen sensitivity in breast cancer. Here, CBX7 is linked to breast carcinoma.